Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Enzymes are natural biocatalysts, harvested and produced from living organisms such as animals, plants, fungi and bacteria. Diagnostic specialty enzymes are used in high value-added and low volume applications. Specialty enzymes are gaining popularity from the past few years due to their potential applications in numerous industries such as biotechnology, pharmaceutical research and diagnostics. In addition, this enzyme is employed in various diagnostic applications such as DNA sequencing and manipulation.
The United States diagnostic specialty enzymes market has been seeing ample growth from the past few years. Market for diagnostic specialty enzymes is majorly driven by growing application of diagnostic specialty enzymes in pharmaceutical and biotechnology industries, and in research and development activities. The eco-friendly and cost-effective feature of specialty enzymes has been resulting in growing adoption in applications in pharmaceutical industries. Moreover, rapidly growing research and development investment in the country’s pharmaceutical industry is further boosting the market growth. For instance, according to the Pharmaceutical Research and Manufacturers Association (PhRMA), the country’s biopharmaceutical organizations conduct more than half the globe’s R&D in pharmaceuticals and hold the intellectual property rights on newest medicines.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the diagnostic specialty enzymes market. In addition, complete analysis of changes on diagnostic specialty enzymes market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The study analyses United States diagnostic specialty enzymes market based on product, application and country.
Various products such as polymerases and nucleases, oxidases, carbohydrates, proteases and others are analyzed in the United States diagnostic specialty enzymes market. The polymerases and nucleases product segment dominated the market and expected to maintain its dominance during the forecast period. The increasing use of polymerase and nuclease enzymes in sophisticated biotechnology applications such as DNA amplification and DNA sequencing is expected to impel market growth. Various local enzyme manufacturers have made substantial investments in the worldwide diagnostic specialized enzymes industry which impels the market growth.
Major applications of the global diagnostic specialty enzymes market are clinical chemistry, immunoassay, and molecular diagnostics. The clinical chemistry segment is further segmented into blood glucose monitoring and POC testing. The clinical chemistry segment is expected to dominate the market during 2021 to 2027. Major growth factors such as increasing adoption of point-of-care testing devices, growing demand for laboratory automation and rising initiatives and funding by the government for preventive care are accredited to the growth of the segment.
The major key players of market include Codexis, Inc, F. Hoffmann-La Roche Ltd, Amano Enzymes Inc, Advanced Enzymes Technologies Ltd, Biocatalysts Ltd, Dyadic International, Affymetrix, Inc and American Laboratories, Inc among others.
October 2020: Roche and Atea Pharmaceuticals, Inc. announced that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral, to people around the world. AT-527 acts by blocking the viral RNA polymerase enzyme required for viral replication, and is presently being studied in a Phase 2 clinical trial for hospitalized patients with moderate COVID-19.
June 2020: Codexis, Inc and Alphazyme LLC, a developing company in the development and manufacture of nucleic acid metabolizing enzymes announced a Co-Marketing & Enzyme Supply Collaboration Agreement for the production and co-marketing of enzymes for life science applications.
February 2019: The subsidiary of Biotec Pharmacon called ArcticZymes introduced its novel ligase enzyme under the name T4 DNA ligase, the most widely used enzyme in the ligase family.
The study analyses United States diagnostic specialty enzymes market based on product, and application. Various products such as polymerases and nucleases, oxidases, carbohydrates, proteases and others are analyzed in the United States diagnostic specialty enzymes market. The polymerases and nucleases segment is likely to dominate the market over the forecast period. Major applications of the United States diagnostic specialty enzymes market are clinical chemistry, immunoassay, and molecular diagnostics. The clinical chemistry segment is likely to register fastest growth in years to come owing to the growing adoption of speciality enzymes in clinical chemistry application.
Why to buy this report:
